DNA Ligase-Based Strategy for Quantifying Heterogeneous DNA Methylation without Sequencing
Author(s) -
Eugene J. H. Wee,
Sakandar Rauf,
Muhammad J. A. Shiddiky,
Alexander Dobrovic,
Matt Trau
Publication year - 2014
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2014.227546
Subject(s) - dna methylation , cpg site , methylation , computational biology , biology , dna , illumina methylation assay , biomarker , bisulfite sequencing , epigenetics , genetics , microbiology and biotechnology , gene , gene expression
DNA methylation is a potential source of disease biomarkers. Typically, methylation levels are measured at individual cytosine/guanine (CpG) sites or over a short region of interest. However, regions of interest often show heterogeneous methylation comprising multiple patterns of methylation (epialleles) on individual DNA strands. Heterogeneous methylation is largely ignored because digital methods are required to deconvolute these usually complex patterns of epialleles. Currently, only single-molecule approaches, such as next generation sequencing (NGS), can provide detailed epiallele information. Because NGS is not yet feasible for routine practice, we developed a single-molecule-like approach, named for epiallele quantification (EpiQ).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom